Skip to main content
NIH funding notice PAS-21-270

AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)

Closed on January 7, 2025.

Posted
September 10, 2021
Close date
January 7, 2025
Activity codes
R03
Institutes taking part
NIDA

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

  1. Reissues: PA-18-916 AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
  2. 2 steps back: PA-18-072 AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
  3. 3 steps back: PA-15-290 AIDS-Science Track Award for Research Transition (R03)
  4. 4 steps back: PA-12-282 AIDS-Science Track Award for Research Transition (R03)
  5. 5 steps back: PAR-10-021 AIDS-Science Track Award for Research Transition (R03)
  6. 6 steps back: PA-07-349 AIDS-Science Track Award for Research Transition (R03)

Replaced by PAS-27-028.

Who won it before

40 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,331,445 in first-year total cost, median $153,302.

Most frequent study sections

  1. HIV Comorbidities and Clinical Studies Study Section[HCCS]7
  2. Special Emphasis Panel[ZRG1 AARR-K (82)]6
  3. Special Emphasis Panel[ZRG1 AARR-N (91)]5
  4. Special Emphasis Panel[ZRG1 AARR-C (82)]4
  5. Special Emphasis Panel[ZRG1 AARR-G (91)]4

Most frequent institutions

  1. FLORIDA INTERNATIONAL UNIVERSITY5
  2. DREXEL UNIVERSITY2
  3. UNIVERSITY OF CALIFORNIA, SAN DIEGO2
  4. UNIVERSITY OF KENTUCKY2
  5. UNIVERSITY OF NEBRASKA MEDICAL CENTER2
Competing awards under PAS-21-270 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Immune profiling of antibodies and B cells that recognize HIV and substances in people who use substances and live with HIV (PWUSH)1R03DA064474-01WU, XUELINGBOSTON MEDICAL CENTER, MA$356,630HIVD
2025Feasibility, Acceptability, and Validity of Remote Sweat-derived Biomarker Collection1R03DA064467-01METHENY, NICHOLASEMORY UNIVERSITY, GA$335,356HCCS
2024Neuroimmune and Cognitive Consequences of Nicotine Use in a Rodent Model of HIV: Implications for Anti-Retroviral Therapies1R03DA061626-01A1GIPSON-REICHARDT, CASSANDRA DUNIVERSITY OF KENTUCKY, KY$166,375HCCS
2024Impact of cannabidiol on HIV infection and methamphetamine abuse associated neuroinflammation1R03DA060076-01CHAND, SUBHASHUNIVERSITY OF NEBRASKA MEDICAL CENTER, NE$153,500HCCS
2024HIV effects on astrocytic regulation of stress-induced cocaine reinstatement1R03DA060771-01A1GIACOMETTI, LAURA LDREXEL UNIVERSITY, PA$151,500HCCS
2022Social networks and STIs as an indicator of potential HIV transmission and acquisition among PWID1R03DA057142-01SKAATHUN, BRITTUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$158,000HIBI
2022Investigate B cell perturbations and immune reconstitution failure in response to antiretroviral therapy in HIV-infected cocaine users1R03DA057164-01JIANG, WEIMEDICAL UNIVERSITY OF SOUTH CAROLINA, SC$151,000HCCS
2022Restoring mucociliary clearance apparatus to mitigate lung inflammation in the context of HIV and cigarette smoke1R03DA057162-01CHINNAPAIYAN, SRINIVASANFLORIDA INTERNATIONAL UNIVERSITY, FL$147,500HCCS
2022Neurocognitive implications of cannabidiol (CBD) while aging with HIV1R03DA057146-01RODRIGUEZ, MYOSOTYSFLORIDA INTERNATIONAL UNIVERSITY, FL$147,500HCCS
2021Substance use, intersectional stigma, and health outcomes for women living with HIV1R03DA052180-01A1 · under PA-18-916TURAN, BULENTUNIVERSITY OF ALABAMA AT BIRMINGHAM, AL$148,500PPAH
2020Phylodynamic Analysis of HIV Transmission Clusters in Kazakhstan for Targeted Interventions1R03DA052179-01 · under PA-18-916ALI, SYEDVERMUND, STEN H.YALE UNIVERSITY, CT$80,871PPAH
2019Alterations in corticostriatal control of cocaine seeking in HIV infection1R03DA047919-01A1 · under PA-18-072BARKER, JACQUELINE MDREXEL UNIVERSITY, PA$167,000ZRG1
2019The impact of abused drug and HIV Tat protein on CRISPR/Cas9 gene editing of HIV provirus in astrocyte reservoir1R03DA048704-01 · under PA-18-072HUANG, ZAOHUAUNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL$153,500ZRG1
2019Modeling combination biomedical substance use interventions to inform a Getting to Zero implementation for Black men who have sex with men1R03DA049662-01 · under PA-18-916KHANNA, ADITYA SUBHASHUNIVERSITY OF CHICAGO, IL$81,000ZRG1
2018Longitudinal impacts of neighborhood factors on HIV care continuum outcomes among Black PWID in Baltimore, MD1R03DA044868-01A1 · under PA-15-290LINTON, SABRIYA LJOHNS HOPKINS UNIVERSITY, MD$163,750BSCH
2018Lung comorbidities in HIV patients1R03DA042681-01A1 · under PA-15-290UNWALLA, HOSHANG JEHANGIRFLORIDA INTERNATIONAL UNIVERSITY, FL$146,500ZRG1
2017Developing a PrEP Screening Instrument for Identification/Referral of High-Risk MSM in Primary Care1R03DA043402-01 · under PA-15-290STORHOLM, ERIK D.RAND CORPORATION, CA$171,422BSPH
2017Migrant Puerto Rican PWID: The Influence of Acculturation and Enculturation on HIV and HCV Risk Behaviors1R03DA041892-01A1 · under PA-15-290GELPI-ACOSTA, CAMILANATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC., NY$159,932ZRG1
2017Preventing HIV/STI in Urban Adolescents via an mHealth Primary Care Intervention1R03DA041891-01A1 · under PA-15-290CORDOVA, DAVIDUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$155,000BSPH
2017Functional identification of new mechanisms of neurotoxicity induced by HIV and drugs of abuse1R03DA043428-01A1 · under PA-15-290SHTUTMAN, MICHAELUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC$146,500ZRG1
2017Intranasal Nanodelivery of Oxytocin to Treat Morphine Addiction in HIV Patients by Gene Editing1R03DA044877-01 · under PA-15-290JAYANT, RAHUL DEVFLORIDA INTERNATIONAL UNIVERSITY, FL$146,500ZRG1
2017An integrated substance use, violence, and HIV/AIDS syndemic risk-reduction intervention for African American Couples1R03DA044866-01 · under PA-15-290MITTAL, MONAUNIV OF MARYLAND, COLLEGE PARK, MD$146,309ZRG1
2016Motives for Heavy Cannabis Use among Young Men who have Sex with Men Living with HIV/AIDS1R03DA041908-01 · under PA-12-282BRUCE, DOUGLASDE PAUL UNIVERSITY, IL$168,845ZRG1
2016Activity Space Neighborhoods, Drug Use and HIV among Black MSM in the Jackson, MS MSA1R03DA039748-01A1 · under PA-12-282DUNCAN, DUSTIN THICKSON, DEMARC ANEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$157,195ZRG1
2016Low-Threshold Incentivized HIV Care for Persons with Substance Use Disorders1R03DA042668-01 · under PA-15-290DOMBROWSKI, JULIA COOKUNIVERSITY OF WASHINGTON, WA$154,500ZRG1
2016Immune dysregulation in HIV-infected adults with substance abuse and the impact of addiction therapy1R03DA039731-01A1 · under PA-12-282LANCIONI, CHRISTINA LOUISEOREGON HEALTH & SCIENCE UNIVERSITY, OR$154,000ZRG1
2016SNS-based Data Mining to Understand MSM Substance use and HIV Risk Behavior1R03DA039752-01A1 · under PA-12-282HOLLOWAY, IAN WALTERUNIVERSITY OF CALIFORNIA LOS ANGELES, CA$154,000ZRG1
2016The impact of marijuana use on brain and cognitive function in HIV-infected patients1R03DA041917-01A1 · under PA-15-290WILSON, TONY WUNIVERSITY OF NEBRASKA MEDICAL CENTER, NE$153,104ZRG1
2016Role of Social Media and Mobile Apps in Sexual and Drug Co-Usage Networks of MSM1R03DA039740-01A1 · under PA-12-282YOUNG, APRIL MARIEUNIVERSITY OF KENTUCKY, KY$152,612ZRG1
2015Characterizing non-medical prescription opioid use and pain in people living with HIV1R03DA039743-01 · under PA-12-282KIPP, AARON MVANDERBILT UNIVERSITY, TN$157,000ZRG1
2015Cocaine mediated downregulation of SAMHD1 facilitates HIV-1 infection in CNS cells1R03DA037782-01A1 · under PA-12-282PILAKKA KANTHIKEEL, SUDHEESHFLORIDA INTERNATIONAL UNIVERSITY, FL$145,000ZRG1
2015HIV-1 Tat inhibition of RNAi: Implications for NeuroAIDS and Substance Abuse1R03DA039733-01 · under PA-12-282KLASE, ZACHARY ALANUNIVERSITY OF THE SCIENCES PHILADELPHIA, PA$142,500ZRG1
2015Increasing rural substance-using African American women's access to evidenced-based HIV intervention1R03DA039744-01 · under PA-12-282HOOD, KRISTINA BEATRICEMISSISSIPPI STATE UNIVERSITY, MS$140,782ZRG1
2015Genome-wide DNA methylation in HIV infected drug users1R03DA039745-01 · under PA-12-282XU, KEYALE UNIVERSITY, CT$130,900ZRG1
2015Informing Dissemination of Behavior Therapies to Enhance HIV Care Among Substance Abusers1R03DA039719-01 · under PA-12-282HARTZLER, BRYAN JUNIVERSITY OF WASHINGTON, WA$125,045ZRG1
2014Exploring transitions to injecting among young adult non-medical opioid users1R03DA037770-01 · under PA-12-282MARSHALL, BRANDON DAVID LEWISBROWN UNIVERSITY, RI$168,719ZRG1
2014Impact of Drug Use Treatment on HIV Risk Behaviors: An Integrative Data Analysis1R03DA037786-01 · under PA-12-282BROWN, JENNIFER LTEXAS TECH UNIVERSITY, TX$158,282ZRG1
2014Economic Debt, Drug Use, and HIV Risk among Sex Workers in Tijuana, Mexico1R03DA035699-01A1 · under PA-12-282REED, ELIZABETH ANNUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$155,000ZRG1
2014Mir-125b/p53/POX axis and HIV-1 induced neurological damage1R03DA037779-01 · under PA-12-282PANDHARE, JUIMEHARRY MEDICAL COLLEGE, TN$145,500NAED
2014The Family as Recovery Capital for HIV-Infected Male Injection Drug Users in Viet1R03DA037783-01 · under PA-12-282LE, GIANG MCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$134,316ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.